A prospective study of the relationship between CRPC patient's quality of life after enzalutamide and serum testosterone levels measured via LC-MS/MS.
JOURNAL OF CLINICAL ONCOLOGY（2022）
摘要
The serum T level before treatment may be useful for predicting QoL changes after ENZ treatment in CRPC patients.
更多查看译文
关键词
LC-MS/MS,androgen,enzalutamide,prostate cancer,quality of life
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要